EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The c‐Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance

Xianteng Wang iD, Bing Wang, Fang Li, Xingkai Li, Ting Guo, Yushun Gao, Dawei Wang, Weiren Huang

Advanced Science · 2023

DOI: 10.1002/advs.202300115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Xianteng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen Uni…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shenzhen Municipal Government of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy resistance and treatment failure hinder clinical cancer treatment. Src , the first mammalian proto‐oncogene to be discovered, is a valuable anti‐cancer therapeutic target. Although several c‐Src inhibitors have reached the clinical stage, drug resistance remains a challenge during treatment. Herein, a positive feedback loop between a previously uncharacterized long non‐coding RNA (lncRNA), which the authors renamed lncRNA‐inducing c‐Src tumor‐promoting function ( LIST ), and c‐Src is uncovered. LIST directly binds to and regulates the Y530 phosphorylation activity of c‐Src. As a c‐Src agonist, LIST promotes tumor chemoresistance and progression in vitro and in vivo in multiple cancer types. c‐Src can positively regulate LIST transcription by activating the NF‐ κ B signaling pathway and then recruiting the P65 transcription factor to the LIST promoter. Interestingly, the LIST /c‐Src interaction is associated with evolutionary new variations of c‐Src. It is proposed that the human‐specific LIST /c‐Src axis renders an extra layer of control over c‐Src activity. Additionally, the LIST /c‐Src axis is of high physiological relevance in cancer and may be a valuable prognostic biomarker and potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingNeoplasmsAnimalsHumansDrug Resistance, NeoplasmFeedbackSignal TransductionMammals

Stichwörter der Autor:innen

LISTP65c-Src, cancerchemoresistanceepigenetic

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Urology, Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Guangdong Key Laboratory for Biomedical Measurements and Ultr…
  • Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
  • Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Chinese Academy of Medical Sciences, Langfang, 065001, China.
  • Department of Thoracic Surgery, Chifeng Municipal Hospital, Chifeng, 024000, China.

ORCID-Profile: Xianteng Wang

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Shenzhen Municipal Government of China
  • Sanming Project of the Shenzhen Health and Family Planning Commission
  • Shenzhen High-Level Hospital Construction Fund
  • Shenzhen Institute of Synthetic Biology Scientific Research Program
  • Wu Jieping Medical Foundation

Zitieren

APA

Wang, X., Wang, B., Li, F., Li, X., Guo, T., Gao, Y., Wang, D., & Huang, W. (2023). The c‐Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance. Advanced Science. https://doi.org/10.1002/advs.202300115

Vancouver

Wang X, Wang B, Li F, Li X, Guo T, Gao Y, et al. The c‐Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance. Advanced Science. 2023. doi:10.1002/advs.202300115

BibTeX
@article{Wang2023,
  author = {Wang, Xianteng and Wang, Bing and Li, Fang and Li, Xingkai and Guo, Ting and Gao, Yushun and Wang, Dawei and Huang, Weiren},
  title = {The c‐Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202300115}
}
Kostenlos starten →